Advances in molecular diagnosis and therapeutics in nephrotic syndrome and focal and segmental glomerulosclerosis.

doi:10.1097/MNH.0000000000000408

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Advances in molecular diagnosis and therapeutics in nephrotic syndrome and focal and segmental glomerulosclerosis.

Current opinion in nephrology and hypertension - 1 May 2018

Sharif Bedra, Barua Moumita

Abstract excerpt

PURPOSE OF REVIEW: The widespread adoption of next-generation sequencing by research and clinical laboratories has begun to uncover the previously unknown genetic basis of many diseases. In nephrology, one of the best examples of this is seen in focal and segmental glomerulosclerosis (FSGS) and nephrotic syndrome. We review advances made in 2017 as a result of human and molecular genetic studies as it relates to...

Topics

Apolipoprotein L1
Collagen Type IV
Genetic Testing
Glomerulosclerosis, Focal Segmental
High-Throughput Nucleotide Sequencing
Humans
Molecular Diagnostic Techniques
Molecular Targeted Therapy
Mutation
Nephrotic Syndrome
Phenotype

Source

Open in PubMed

Identifiers

PMID: 29465426
DOI: 10.1097/MNH.0000000000000408

Genes

NPHS1
NPHS2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics